10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 322 filers reported holding 10X GENOMICS INC in Q1 2021. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,723,631 | -24.5% | 41,785 | +2.3% | 0.10% | -21.4% |
| Q2 2023 | $2,281,901 | -0.4% | 40,865 | -0.5% | 0.13% | -6.7% |
| Q1 2023 | $2,291,574 | +74.9% | 41,075 | +14.3% | 0.14% | +66.7% |
| Q4 2022 | $1,309,981 | +34.1% | 35,949 | +4.8% | 0.08% | +20.9% |
| Q3 2022 | $977,000 | -46.0% | 34,308 | -14.2% | 0.07% | -43.7% |
| Q2 2022 | $1,808,000 | -41.0% | 39,972 | -0.8% | 0.12% | -29.6% |
| Q1 2022 | $3,066,000 | -40.6% | 40,303 | +16.3% | 0.17% | -35.0% |
| Q4 2021 | $5,161,000 | +8.2% | 34,651 | +5.8% | 0.26% | -0.8% |
| Q3 2021 | $4,768,000 | +7.6% | 32,749 | +44.7% | 0.26% | +6.5% |
| Q2 2021 | $4,433,000 | +25.4% | 22,638 | +15.9% | 0.25% | +16.0% |
| Q1 2021 | $3,536,000 | – | 19,534 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
| Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
| Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
| Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
| Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
| Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
| RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
| Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
| Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |